Evidence map›Paper›PMID 36195583›Full record

ArticleNature communications2022

Tubular cell polyploidy protects from lethal acute kidney injury but promotes consequent chronic kidney disease.

Letizia De Chiara, Carolina Conte, Roberto Semeraro, Paula Diaz-Bulnes, Maria Lucia Angelotti, Benedetta Mazzinghi, Alice Molli, Giulia Antonelli, Samuela Landini, Maria Elena Melica and 17 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 68 citations in OpenAlex.

  1. Review
  2. Review
  3. Targeting YAP1-Mediated Tubular Cell Senescence to Attenuate Maladaptive Repair and Fibrotic Transition After Acute Kidney Injury.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  4. Review
  5. Review
  6. Growth under pressure: The pros and cons of polyploidy induced by stress.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 6 institutions in 3 countries.

Letizia De ChiaraDepartment of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, 50139, Italy.
Carolina ConteDepartment of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, 50139, Italy.
Roberto SemeraroDepartment of Experimental and Clinical Medicine, University of Florence, Florence, 50139, Italy.
Paula Diaz-BulnesTranslational immunology, Instituto de Investigación Sanitaria del Principado de Asturias ISPA, 33011, Oviedo, Asturias, España.
Maria Lucia AngelottiDepartment of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, 50139, Italy.
Benedetta MazzinghiNephrology and Dialysis Unit, Meyer Children's University Hospital, Florence, 50139, Italy.
Alice MolliDepartment of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, 50139, Italy.
Giulia AntonelliDepartment of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, 50139, Italy.
Samuela LandiniMedical Genetics Unit, Meyer Children's University Hospital, Florence, 50139, Italy.ORCID 0000-0001-7423-0325
Maria Elena MelicaDepartment of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, 50139, Italy.
Anna Julie PeiredDepartment of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, 50139, Italy.ORCID 0000-0001-9732-1369
Laura MaggiDepartment of Experimental and Clinical Medicine, University of Florence, Florence, 50139, Italy.ORCID 0000-0003-2862-9591
Marta DonatiDepartment of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, 50139, Italy.
Gilda La ReginaDepartment of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, 50139, Italy.
Marco AllinoviNephrology, Dialysis and Transplantation Unit, Careggi University Hospital, Florence, 50134, Italy.
Fiammetta RavagliaNephrology and Dialysis Unit, Santo Stefano Hospital, Prato, 59100, Italy.ORCID 0000-0001-7121-2324
Daniele GuastiDepartment of Experimental & Clinical Medicine, Imaging Platform, University of Florence, Florence, 50139, Italy.
Daniele BaniDepartment of Experimental & Clinical Medicine, Imaging Platform, University of Florence, Florence, 50139, Italy.ORCID 0000-0001-6302-901X
Luigi CirilloDepartment of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, 50139, Italy.ORCID 0000-0002-0440-7356
Francesca BecherucciNephrology and Dialysis Unit, Meyer Children's University Hospital, Florence, 50139, Italy.
Francesco GuzziNephrology and Dialysis Unit, Santo Stefano Hospital, Prato, 59100, Italy.ORCID 0000-0003-0788-5078
Alberto MagiDepartment of Information Engineering, University of Florence, Florence, 50139, Italy.
Francesco AnnunziatoDepartment of Experimental and Clinical Medicine, University of Florence, Florence, 50139, Italy.ORCID 0000-0001-8798-7589
Laura LasagniDepartment of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, 50139, Italy.
Hans-Joachim AndersDivision of Nephrology, Department of Internal Medicine IV, LMU Hospital, Munich, 80336, Germany.
Elena Lazzeri *Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, 50139, Italy. elena.lazzeri@unifi.it.ORCID 0000-0002-9505-2115
Paola Romagnani *Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, 50139, Italy. paola.romagnani@unifi.it.ORCID 0000-0002-1774-8088
University of Florence · ITMeyer Children's Hospital · ITAzienda Ospedaliero-Universitaria Careggi · ITHospital of Prato · ITInstituto de Investigación Sanitaria del Principado de Asturias · ESLMU Klinikum · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute kidney injury (AKI) is frequent, often fatal and, for lack of specific therapies, can leave survivors with chronic kidney disease (CKD). We characterize the distribution of tubular cells (TC) undergoing polyploidy along AKI by DNA content analysis and single cell RNA-sequencing. Furthermore, we study the functional roles of polyploidization using transgenic models and drug interventions. We identify YAP1-driven TC polyploidization outside the site of injury as a rapid way to sustain residual kidney function early during AKI. This survival mechanism comes at the cost of senescence of polyploid TC promoting interstitial fibrosis and CKD in AKI survivors. However, targeting TC polyploidization after the early AKI phase can prevent AKI-CKD transition without influencing AKI lethality. Senolytic treatment prevents CKD by blocking repeated TC polyploidization cycles. These results revise the current pathophysiological concept of how the kidney responds to acute injury and identify a novel druggable target to improve prognosis in AKI survivors.

Indexed as

Acute Kidney InjuryRenal Insufficiency, ChronicDisease ProgressionDNAHumansKidneyPolyploidyRNASenotherapeuticsDNARNASenotherapeutics

Identifiers

PMID36195583
PMCPMC9532438
OpenAlexW4300971964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.